Genetic engineering of bacteriophages : Key concepts, strategies, and applications
Copyright © 2023. Published by Elsevier Inc..
Bacteriophages are the most abundant biological entity in the world and hold a tremendous amount of unexplored genetic information. Since their discovery, phages have drawn a great deal of attention from researchers despite their small size. The development of advanced strategies to modify their genomes and produce engineered phages with desired traits has opened new avenues for their applications. This review presents advanced strategies for developing engineered phages and their potential antibacterial applications in phage therapy, disruption of biofilm, delivery of antimicrobials, use of endolysin as an antibacterial agent, and altering the phage host range. Similarly, engineered phages find applications in eukaryotes as a shuttle for delivering genes and drugs to the targeted cells, and are used in the development of vaccines and facilitating tissue engineering. The use of phage display-based specific peptides for vaccine development, diagnostic tools, and targeted drug delivery is also discussed in this review. The engineered phage-mediated industrial food processing and biocontrol, advanced wastewater treatment, phage-based nano-medicines, and their use as a bio-recognition element for the detection of bacterial pathogens are also part of this review. The genetic engineering approaches hold great potential to accelerate translational phages and research. Overall, this review provides a deep understanding of the ingenious knowledge of phage engineering to move them beyond their innate ability for potential applications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
---|---|
Enthalten in: |
Biotechnology advances - 64(2023) vom: 15. Mai, Seite 108116 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hussain, Wajid [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 24.03.2023 Date Revised 24.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.biotechadv.2023.108116 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352834080 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352834080 | ||
003 | DE-627 | ||
005 | 20231226054629.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.biotechadv.2023.108116 |2 doi | |
028 | 5 | 2 | |a pubmed24n1176.xml |
035 | |a (DE-627)NLM352834080 | ||
035 | |a (NLM)36773707 | ||
035 | |a (PII)S0734-9750(23)00023-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hussain, Wajid |e verfasserin |4 aut | |
245 | 1 | 0 | |a Genetic engineering of bacteriophages |b Key concepts, strategies, and applications |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.03.2023 | ||
500 | |a Date Revised 24.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023. Published by Elsevier Inc. | ||
520 | |a Bacteriophages are the most abundant biological entity in the world and hold a tremendous amount of unexplored genetic information. Since their discovery, phages have drawn a great deal of attention from researchers despite their small size. The development of advanced strategies to modify their genomes and produce engineered phages with desired traits has opened new avenues for their applications. This review presents advanced strategies for developing engineered phages and their potential antibacterial applications in phage therapy, disruption of biofilm, delivery of antimicrobials, use of endolysin as an antibacterial agent, and altering the phage host range. Similarly, engineered phages find applications in eukaryotes as a shuttle for delivering genes and drugs to the targeted cells, and are used in the development of vaccines and facilitating tissue engineering. The use of phage display-based specific peptides for vaccine development, diagnostic tools, and targeted drug delivery is also discussed in this review. The engineered phage-mediated industrial food processing and biocontrol, advanced wastewater treatment, phage-based nano-medicines, and their use as a bio-recognition element for the detection of bacterial pathogens are also part of this review. The genetic engineering approaches hold great potential to accelerate translational phages and research. Overall, this review provides a deep understanding of the ingenious knowledge of phage engineering to move them beyond their innate ability for potential applications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a BRED | |
650 | 4 | |a Bacterial detection | |
650 | 4 | |a CRISPR | |
650 | 4 | |a Drug delivery | |
650 | 4 | |a Endolysins | |
650 | 4 | |a Engineered bacteriophage | |
650 | 4 | |a Phage display | |
650 | 4 | |a Phage therapy | |
650 | 4 | |a Phage typing | |
650 | 4 | |a Phage-based vaccines | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Yang, Xiaohan |e verfasserin |4 aut | |
700 | 1 | |a Ullah, Mati |e verfasserin |4 aut | |
700 | 1 | |a Wang, Huan |e verfasserin |4 aut | |
700 | 1 | |a Aziz, Ayesha |e verfasserin |4 aut | |
700 | 1 | |a Xu, Fang |e verfasserin |4 aut | |
700 | 1 | |a Asif, Muhammad |e verfasserin |4 aut | |
700 | 1 | |a Ullah, Muhammad Wajid |e verfasserin |4 aut | |
700 | 1 | |a Wang, Shenqi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biotechnology advances |d 1983 |g 64(2023) vom: 15. Mai, Seite 108116 |w (DE-627)NLM083784144 |x 1873-1899 |7 nnns |
773 | 1 | 8 | |g volume:64 |g year:2023 |g day:15 |g month:05 |g pages:108116 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biotechadv.2023.108116 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 64 |j 2023 |b 15 |c 05 |h 108116 |